SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Garaci F.)
 

Sökning: WFRF:(Garaci F.) > (2015-2019) > Evolving Evidence f...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00005024naa a2200805 4500
001oai:gup.ub.gu.se/224867
003SwePub
008240528s2015 | |||||||||||000 ||eng|
024a https://gup.ub.gu.se/publication/2248672 URI
024a https://doi.org/10.3233/jad-1502022 DOI
040 a (SwePub)gu
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Lista, S.4 aut
2451 0a Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline
264 1b IOS Press,c 2015
520 a There is evolving evidence that individuals categorized with subjective cognitive decline (SCD) are potentially at higher risk for developing objective and progressive cognitive impairment compared to cognitively healthy individuals without apparent subjective complaints. Interestingly, SCD, during advancing preclinical Alzheimer's disease (AD), may denote very early, subtle cognitive decline that cannot be identified using established standardized tests of cognitive performance. The substantial heterogeneity of existing SCD-related research data has led the Subjective Cognitive Decline Initiative (SCD-I) to accomplish an international consensus on the definition of a conceptual research framework on SCD in preclinical AD. In the area of biological markers, the cerebrospinal fluid signature of AD has been reported to be more prevalent in subjects with SCD compared to healthy controls; moreover, there is a pronounced atrophy, as demonstrated by magnetic resonance imaging, and an increased hypometabolism, as revealed by positron emission tomography, in characteristic brain regions affected by AD. In addition, SCD individuals carrying an apolipoprotein epsilon 4 allele are more likely to display AD-phenotypic alterations. The urgent requirement to detect and diagnose AD as early as possible has led to the critical examination of the diagnostic power of biological markers, neurophysiology, and neuroimaging methods for AD-related risk and clinical progression in individuals defined with SCD. Observational studies on the predictive value of SCD for developing AD may potentially be of practical value, and an evidence-based, validated, qualified, and fully operationalized concept may inform clinical diagnostic practice and guide earlier designs in future therapy trials.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Neurovetenskaper0 (SwePub)301052 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Neurosciences0 (SwePub)301052 hsv//eng
653 a Alzheimer's disease
653 a biological markers
653 a blood-based biomarkers
653 a cerebrospinal fluid biomarkers
653 a beta-amyloid 1-42
653 a alzheimers association workgroups
653 a transcranial
653 a magnetic stimulation
653 a cerebrospinal-fluid biomarkers
653 a white-matter
653 a hyperintensities
653 a heterogeneous brain-tissue
653 a gaussian water diffusion
653 a blood-based biomarkers
653 a temporal-lobe atrophy
653 a pittsburgh-compound-b
653 a Neurosciences & Neurology
653 a C 02-04
653 a 2007
653 a Las Vegas
653 a NV
653 a V4
653 a PS98
700a Molinuevo, J. L.4 aut
700a Cavedo, E.4 aut
700a Rami, L.4 aut
700a Amouyel, P.4 aut
700a Teipel, S. J.4 aut
700a Garaci, F.4 aut
700a Toschi, N.4 aut
700a Habert, M. O.4 aut
700a Blennow, Kaj,d 1958u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry4 aut0 (Swepub:gu)xbleka
700a Zetterberg, Henrik,d 1973u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry4 aut0 (Swepub:gu)xzethe
700a O'Bryant, S. E.4 aut
700a Johnson, L.4 aut
700a Galluzzi, S.4 aut
700a Bokde, A. L. W.4 aut
700a Broich, K.4 aut
700a Herholz, K.4 aut
700a Bakardjian, H.4 aut
700a Dubois, B.4 aut
700a Jessen, F.4 aut
700a Carrillo, M. C.4 aut
700a Aisen, P. S.4 aut
700a Hampel, H.4 aut
710a Göteborgs universitetb Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi4 org
773t Journal of Alzheimers Diseased : IOS Pressg 48q 48x 1387-2877x 1875-8908
8564 8u https://gup.ub.gu.se/publication/224867
8564 8u https://doi.org/10.3233/jad-150202

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy